Health Care • Medical/Dental Instruments
$59.05 ▼ -1.48
(-2.44%)
MKT CAP: $5.26B • VOL: 2.25M
52W L $20 52W H $61
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$50
MEDIAN
$66
MEAN
$67
HIGH
$80
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE HTFL TAPE
HTFL // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $71.45 | $67.91 | 2025-02-14 | $53.74 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $74.40 | $69.68 | 2025-02-06 | $55.51 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $67.32 | $64.95 | 2025-01-29 | $56.69 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $60.23 | — | 2025-01-17 | $57.87 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $51.96 | $56.10 | 2025-01-09 | $52.55 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $70.27 | $61.41 | 2024-12-18 | $51.37 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $57.28 | $59.64 | 2024-12-04 | $54.92 | -4.3% | 48% | C |